New shot aims to lower bad cholesterol in early trial
NCT ID NCT07229118
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new injectable drug, COR-1004, for safety and proper dosing in people with high LDL (bad) cholesterol. About 60 healthy volunteers who are not on cholesterol meds will receive a single shot of the drug or a placebo. Researchers will monitor side effects and cholesterol levels for a year to guide future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Trial Site
RECRUITINGChristchurch, 6011, New Zealand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two experimental pills work together safely? a trial seeks answers
- Can a new pill tame high cholesterol? a phase 1 trial puts SAL0167 to the test
- Gut bacteria may tame pancreatitis — probiotic combo put to the test
- Fatty meals may trap vitamin e in the blood, study suggests
- Could vinegar and fasting fix prediabetes cholesterol?
- Could a monthly shot beat biweekly for lowering cholesterol?